Literature DB >> 18201835

Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.

P M Aponso1, R L M Faull, B Connor.   

Abstract

The existence of endogenous progenitor cells in the adult mammalian brain presents an exciting and attractive alternative to existing therapeutic options for treating neurodegenerative diseases such as Parkinson's disease (PD). However, prior to designing endogenous cell therapies, the effect of PD neuropathology on endogenous progenitor cell proliferation and their neurogenic potential must be investigated. This study examined the effect of dopaminergic cell loss on the proliferation and differentiation of subventricular zone- (SVZ) and midbrain-derived progenitor cells in the adult rodent brain, using the partial progressive 6-hydroxydopamine (6-OHDA) lesion model of PD. Cell proliferation and differentiation were assessed with 5-bromo-2'-deoxyuridine (BrdU) labeling and immunohistochemistry for cell type-specific markers. Tyrosine hydroxylase immunohistochemistry demonstrated a complete loss of nigrostriatal projections in the striatum and a subsequent progressive loss of dopamine (DA) cells in the SN. Quantification indicated that 6-OHDA lesion-induced cell degeneration produced a significant increase in BrdU immunoreactivity in the SVZ, ipsilateral to the lesioned hemisphere from 3 to 21 days post-lesion, compared with sham-lesioned animals. Similarly, in the striatum we observed a significant increase in the total number of BrdU positive cells in 6-OHDA-lesioned animals at all time points examined. More importantly, a significant increase in midbrain-derived BrdU positive cells was demonstrated in 6-OHDA-lesioned animals 28 days post-lesion. While we did not detect neurogenesis, BrdU labeled cells co-expressing the astrocytic marker glial fibrillary acidic protein (GFAP) were widely distributed throughout the 6-OHDA-lesioned striatum at all time points. In contrast, BrdU-labeled cells in the SN of 6-OHDA-lesioned animals did not co-express neural markers. These results demonstrate that DA-ergic neurodegeneration in the partial progressive 6-OHDA-lesioned rat brain increases SVZ- and midbrain-derived progenitor cell proliferation. While, newborn striatal progenitors undergo robust astrogenesis, newborn midbrain-derived progenitors remain in an undifferentiated state suggesting local environments differentially regulate endogenous progenitor cell populations in PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18201835     DOI: 10.1016/j.neuroscience.2007.11.036

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  35 in total

1.  Modulation of Postnatal Neurogenesis by Perinatal Asphyxia: Effect of D1 and D2 Dopamine Receptor Agonists.

Authors:  A Tapia-Bustos; R Perez-Lobos; V Vío; C Lespay-Rebolledo; E Palacios; A Chiti-Morales; D Bustamante; M Herrera-Marschitz; P Morales
Journal:  Neurotox Res       Date:  2016-09-16       Impact factor: 3.911

2.  Effects of treadmill exercise on behavioral recovery and neural changes in the substantia nigra and striatum of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse.

Authors:  Beth A Smith; Natalie R S Goldberg; Charles K Meshul
Journal:  Brain Res       Date:  2011-03-21       Impact factor: 3.252

3.  Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian rats.

Authors:  Jose A Morales-Garcia; Sandra Alonso-Gil; Carmen Gil; Ana Martinez; Angel Santos; Ana Perez-Castillo
Journal:  Stem Cells Transl Med       Date:  2015-04-29       Impact factor: 6.940

Review 4.  Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.

Authors:  Jaclyn Nicole Le Grand; Laura Gonzalez-Cano; Maria Angeliki Pavlou; Jens C Schwamborn
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

5.  A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.

Authors:  Marylou V Solbrig; Yijun Fan; Neal Hermanowicz; Maria Grazia Morgese; Andrea Giuffrida
Journal:  Exp Neurol       Date:  2010-09-09       Impact factor: 5.330

Review 6.  Adult neurogenesis in Parkinson's disease.

Authors:  Franz Marxreiter; Martin Regensburger; Jürgen Winkler
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

7.  Stimulation of the rat subthalamic nucleus is neuroprotective following significant nigral dopamine neuron loss.

Authors:  A L Spieles-Engemann; M M Behbehani; T J Collier; S L Wohlgenant; K Steece-Collier; K Paumier; B F Daley; S Gombash; L Madhavan; G T Mandybur; J W Lipton; B T Terpstra; C E Sortwell
Journal:  Neurobiol Dis       Date:  2010-03-20       Impact factor: 5.996

8.  Synaptic Regulator α-Synuclein in Dopaminergic Fibers Is Essentially Required for the Maintenance of Subependymal Neural Stem Cells.

Authors:  Ana Perez-Villalba; M Salomé Sirerol-Piquer; Germán Belenguer; Raúl Soriano-Cantón; Ana Belén Muñoz-Manchado; Javier Villadiego; Diana Alarcón-Arís; Federico N Soria; Benjamin Dehay; Erwan Bezard; Miquel Vila; Analía Bortolozzi; Juan José Toledo-Aral; Francisco Pérez-Sánchez; Isabel Fariñas
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

Review 9.  Towards a Better Treatment Option for Parkinson's Disease: A Review of Adult Neurogenesis.

Authors:  Parisa Farzanehfar
Journal:  Neurochem Res       Date:  2016-09-10       Impact factor: 3.996

10.  Enriched environment protects the nigrostriatal dopaminergic system and induces astroglial reaction in the 6-OHDA rat model of Parkinson's disease.

Authors:  Agustín Anastasía; Luciana Torre; Gabriel A de Erausquin; Daniel H Mascó
Journal:  J Neurochem       Date:  2009-02-20       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.